so next quarter will have the SIOI order of US$185k or $284kAus.
"The first purchase order for US$185,000 has been received and will ship in August upon payment prior to the shipment of product."
expect this revenue to increase on approval of SIOI new vaccines as posted yesterday
then we have the launch of anteobindNXT,
"Sales revenues are expected to build in FY2025."
then we have ev1
"In parallel, EV1 has advised that they will be accelerating their assessment of higher silicon anodes (>20%) and they expect to purchase some proprietary high silicon anodes from AnteoTech in 1H FY25."
"This increased exposure to EV1’s development provides potential opportunities for both Anteo X sales and licencing revenues for the high silicon anodes (including development contracts)."
development contracts should be in play for many of our CET partners and if you look at this further, if anteotch didn't have a functioning >70% silicon anode at close to 1000 cycles, would we be selling it to ev1. so much anticipated news from our high silicon anode program should be expected !!!
then we have biosecurity
"During the Quarter, an initial, paid development project was undertaken with an Australian State Government department"
all starting as a trickle, but with the possibility of exponential growth. management lack marketing the company but IMO doing an excellent job of building a company. again, IMO so flip floppers, don't get your knickers in a knot
GLTAH............
- Forums
- ASX - By Stock
- why ADO is a multi multi bagger
ADO
anteotech ltd
Add to My Watchlist
0.00%
!
1.4¢

so next quarter will have the SIOI order of US$185k or $284kAus....
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.87M |
Open | High | Low | Value | Volume |
1.5¢ | 1.5¢ | 1.4¢ | $12.64K | 886.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 1057201 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.5¢ | 4211074 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 1057201 | 0.014 |
6 | 1159222 | 0.013 |
6 | 2041372 | 0.012 |
7 | 2658674 | 0.011 |
7 | 3309000 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.015 | 3776793 | 10 |
0.016 | 1427582 | 2 |
0.017 | 218695 | 4 |
0.018 | 1186369 | 5 |
0.019 | 1117333 | 8 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online